Scientific Advisory Board

Display #
Name Position
Paul B. Watkins, M.D.
Paul B. Watkins, M.D.
Director, the DILI-sim Initiative | Chairman, DILI-sim Scientific Advisory Board | Director, UNC Institute for Drug Safety Sciences
David S. Pisetsky, M.D., Ph.D.
David S. Pisetsky, M.D., Ph.D.
Professor of Medicine (Rheumatology and Immunology) Duke University
Kevin Park, Ph.D., FMedSci, FRCP (Hon), FTBS
Kevin Park, Ph.D., FMedSci, FRCP (Hon), FTBS
Professor of Molecular and Clinical Pharmacology, Director of MRC Centre for Drug Safety Science, and Head of the Institute of Translational Medicine University of Liverpool
Mark Avigan, M.D., C.M.
Mark Avigan, M.D., C.M.
Associate Director of Critical Path Initiatives Food and Drug Administration (USA)
Neil Kaplowitz, M.D.
Neil Kaplowitz, M.D.
Professor of Medicine Chief Division of Gastrointestinal and Liver Disease University of Southern California Liver Transplant Program and Center for Liver Disease University of Southern California
Robert A. Roth, Ph.D., DABT
Robert A. Roth, Ph.D., DABT
Distinguished Professor, Professor of Pharmacology & Toxicology Director, Graduate Training Program in Environmental and Integrative Toxicological Sciences, Center for Integrative Toxicology, Michigan State University
Jack Uetrecht, M.D., Ph.D.
Jack Uetrecht, M.D., Ph.D.
Professor of Pharmacy and Medicine and Canada Research Chair in Adverse Drug Reactions, University of Toronto

Companies Supporting DILIsym® Software Development

2016 04 DILIsim Consortium 2